As of Feb 17
| +0.04 / +3.77%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a -9.09% decrease from the last price of 1.10.
The current consensus among 2 polled investment analysts is to Hold stock in Opexa Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.